In a recent study, scientists from the CCMB presented their analysis of over 5,000 variants of the virus detected through genome sequencing in India over the last one year.
Speaking to Express, the CCMB Director, Dr Rakesh Mishra said the RNA platform is expected to be ready within six months.
8 new variants of CYP2C9 gene, which plays an essential role in metabolising drugs, found
The findings prove the effectiveness of physical distancing as the study shows the virus does not seem to spread farther away from the patients, especially if they are asymptomatic.
The Telangana state Health Department had tracked nearly 90% of all UK returnees in the last 72 hours and tested them.
The test kit has been developed by CSIR-CCMB and the collaboration with Apollo will focus on scaling up production and commercialisation of the tests jointly.
ICMR Director General, Dr Shekhar C Mande, said that the Dry-Swab Direct RT-PCR can help in ramping up Covid-19 testing capacity of the country in a short time frame.
Dr Rakesh Mishra also said it might take a couple of years for a successful vaccine candidate to prove its efficacy among people of all ages
Impact of domestication has been observed on genes which are associated with milk yield, disease resistance, stature, and birth weight. These genes can be edited, in order to enhance them
His remarks come in the backdrop of Russian President Vladimir Putin's announcement that his country has developed the world's first vaccine against coronavirus.
The institute had started a genome research on the samples of Covid-19-positive patients in the State in May.
He said that thousands of people are given vaccine during clinical trials and one has to wait for the data and results, which normally takes months.
GEAR-2019 gives an interesting peak into the outcome of the efforts put in by scientists and researchers from 33 laboratories across India for sequencing 1,031 genomes of the novel coronavirus.
This new technique is based on a ‘genetic risk score’, which considers detailed information at the genetic level of genetic areas that are known to increase the chance of developing type 1 diabetes.
The RT-nPCR test would come handy for those labs that do not own or have the capacity to afford the ‘real time thermal cycler’ machine, which is required to conduct the RT-qPCR test.